86 related articles for article (PubMed ID: 30125974)
1. Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
Hesari A; Ghasemi F; Cicero AFG; Mohajeri M; Rezaei O; Hayat SMG; Sahebkar A
J Cell Biochem; 2018 Dec; 119(12):9655-9663. PubMed ID: 30125974
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effects of berberine for gastrointestinal cancers.
Davoodvandi A; Sadeghi S; Alavi SMA; Alavi SS; Jafari A; Khan H; Aschner M; Mirzaei H; Sharifi M; Asemi Z
Asia Pac J Clin Oncol; 2024 Apr; 20(2):152-167. PubMed ID: 36915942
[TBL] [Abstract][Full Text] [Related]
3. Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression.
Calvani M; Subbiani A; Bruno G; Favre C
Oxid Med Cell Longev; 2020; 2020():7534693. PubMed ID: 32855766
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
[TBL] [Abstract][Full Text] [Related]
5. Berberine and barberry (Berberis vulgaris): A clinical review.
Imenshahidi M; Hosseinzadeh H
Phytother Res; 2019 Mar; 33(3):504-523. PubMed ID: 30637820
[TBL] [Abstract][Full Text] [Related]
6. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.
Feng X; Sureda A; Jafari S; Memariani Z; Tewari D; Annunziata G; Barrea L; Hassan STS; Šmejkal K; Malaník M; Sychrová A; Barreca D; Ziberna L; Mahomoodally MF; Zengin G; Xu S; Nabavi SM; Shen AZ
Theranostics; 2019; 9(7):1923-1951. PubMed ID: 31037148
[TBL] [Abstract][Full Text] [Related]
7. Berberine: A novel therapeutic strategy for cancer.
Samadi P; Sarvarian P; Gholipour E; Asenjan KS; Aghebati-Maleki L; Motavalli R; Hojjat-Farsangi M; Yousefi M
IUBMB Life; 2020 Oct; 72(10):2065-2079. PubMed ID: 32735398
[TBL] [Abstract][Full Text] [Related]
8. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies.
Liu DQ; Chen SP; Sun J; Wang XM; Chen N; Zhou YQ; Tian YK; Ye DW
Pharmacol Res; 2019 Oct; 148():104385. PubMed ID: 31400402
[TBL] [Abstract][Full Text] [Related]
9. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance.
Mortazavi H; Nikfar B; Esmaeili SA; Rafieenia F; Saburi E; Chaichian S; Heidari Gorji MA; Momtazi-Borojeni AA
Eur J Med Chem; 2020 Feb; 187():111951. PubMed ID: 31821990
[TBL] [Abstract][Full Text] [Related]
10. [Berberine as a potential therapeutic agent in the treatment of acute pancreatitis].
Tarasiuk A; Pawlik L; Fichna J
Postepy Biochem; 2019 Oct; 65(3):224-230. PubMed ID: 31643170
[TBL] [Abstract][Full Text] [Related]
11. Biological properties and clinical applications of berberine.
Song D; Hao J; Fan D
Front Med; 2020 Oct; 14(5):564-582. PubMed ID: 32335802
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of berberine.
Warowicka A; Nawrot R; Goździcka-Józefiak A
Arch Virol; 2020 Sep; 165(9):1935-1945. PubMed ID: 32594322
[TBL] [Abstract][Full Text] [Related]
13. Berberine as a Potential Anticancer Agent: A Comprehensive Review.
Rauf A; Abu-Izneid T; Khalil AA; Imran M; Shah ZA; Emran TB; Mitra S; Khan Z; Alhumaydhi FA; Aljohani ASM; Khan I; Rahman MM; Jeandet P; Gondal TA
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885950
[TBL] [Abstract][Full Text] [Related]
14. Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer.
Kou Y; Tong B; Wu W; Liao X; Zhao M
Front Pharmacol; 2020; 11():616251. PubMed ID: 33362566
[TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits the progression of renal cell carcinoma cells by regulating reactive oxygen species generation and inducing DNA damage.
Zhao Y; Lin X; Zeng W; Qin X; Miao B; Gao S; Liu J; Li Z
Mol Biol Rep; 2023 Jul; 50(7):5697-5707. PubMed ID: 37217616
[TBL] [Abstract][Full Text] [Related]
16. Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC.
Yuan R; Tan Y; Sun PH; Qin B; Liang Z
Front Pharmacol; 2023; 14():1122890. PubMed ID: 36937842
[No Abstract] [Full Text] [Related]
17. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
Zhu C; Li K; Peng XX; Yao TJ; Wang ZY; Hu P; Cai D; Liu HY
Front Immunol; 2022; 13():1083788. PubMed ID: 36561763
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review.
Xiong RG; Huang SY; Wu SX; Zhou DD; Yang ZJ; Saimaiti A; Zhao CN; Shang A; Zhang YJ; Gan RY; Li HB
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889396
[TBL] [Abstract][Full Text] [Related]
19. Current Advances in
He L; Zhong Z; Chen M; Liang Q; Wang Y; Tan W
Front Pharmacol; 2021; 12():775084. PubMed ID: 35046810
[No Abstract] [Full Text] [Related]
20. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
